Indications for Use: The drug is indicated for use in pregnant women 18 years of age and older at risk of preterm labour in the following situations:

·       regular uterine contractions of at least 30 seconds duration and frequency of 4 or more times within 30 minutes;

·       cervical opening of 1 to 3 cm (0 to 3 cm in nulliparous women) and cervical smoothing of more than 50 per cent;

·       gestational age between 24 and 33 full weeks;

·       normal fetal heart rate.

This product is included in the Essential Drug List (EDL).

Regulatory Status: Rx only.

THERE ARE CONTRAINDICATIONS. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of Atosiban PSK (INN: atosiban), lyophilisate, 7.5 mg/ml leaflet, please visit this website: https://grls.rosminzdrav.ru/Default.aspx.